Japan-made coronavirus vaccines may not be available until 2022 - (The Japan Times via NewsPoints Desk)

  • Vaccines against COVID-19 that have been developed in Japan are unlikely to be available until at least 2022, The Japan Times reported.

  • Only one company in Japan, AnGes, is conducting a trial of a vaccine, after a Phase II study started last month.

  • The company initially aimed to receive approval of the vaccine next spring, but the timing is now uncertain as it needs to conduct a trial covering several tens of thousands of people.

  • Meanwhile, Shionogi is developing a COVID-19 vaccine, with plans to launch a trial by the end of this year and conduct a large-scale study covering people in and outside Japan next year.

  • In addition, KM Biologics and Daiichi Sankyo Co. are set to launch a trial in March 2021, with ID Pharma expected to do so between March and May next year.

To read more NewsPoints articles, click here.